Article type
Abstract
Background: Clinical practice guidelines are a crucial foundation for conducting medical practices scientifically and serve as a means to promptly translate medical research evidence. The quality of these guidelines relies on the meticulousness of their development methods and adherence to standardized processes. Taking economic evidence into account can facilitate a comprehensive evaluation of the efficacy of treatment methods during the formulation of clinical practice guidelines. This consideration ensures the rational use of medical resources and the overall benefit of patients.
Objectives: The purpose of this study is to identify critical issues associated with health economic evidence during the development of guidelines and establish standardized reporting protocols for health economic evidence in guidelines.
Methods: Drawing on the methods of developing international reporting standards and the development approach of the RIGHT statement, this study integrates research from three aspects: (1) using systematic review methods to analyze the content of health economic evidence-related policies in current guideline development manuals, aiming to identify existing issues in the policies regarding health economic evidence in current guidelines. (2) Employing cross-sectional survey methods to analyze the reporting status of health economic evidence during the formation of guideline recommendations over the past 3 years, examining the current status and issues of health economic evidence reporting in guidelines. (3) Conducting a questionnaire survey to investigate the awareness and information needs of guideline stakeholders regarding health economic evidence in current guidelines. By combining these findings, an initial item pool will be formed. The Delphi method and consensus conference approach will be utilized to establish the RIGHT-Health Economics Checklist.
Results: Preliminary research findings indicate that in the process of guideline development, it is necessary to report on aspects such as whether health economists are included in the guideline panel, how economic evidence is retrieved, the types of economic evidence, the evaluation and summary of economic evidence, the integration of economic evidence with other types of evidence for recommendations, and the consideration of economic levels at the regional level. The remaining research is still ongoing, and the results will be completed before July 1, 2024.
Objectives: The purpose of this study is to identify critical issues associated with health economic evidence during the development of guidelines and establish standardized reporting protocols for health economic evidence in guidelines.
Methods: Drawing on the methods of developing international reporting standards and the development approach of the RIGHT statement, this study integrates research from three aspects: (1) using systematic review methods to analyze the content of health economic evidence-related policies in current guideline development manuals, aiming to identify existing issues in the policies regarding health economic evidence in current guidelines. (2) Employing cross-sectional survey methods to analyze the reporting status of health economic evidence during the formation of guideline recommendations over the past 3 years, examining the current status and issues of health economic evidence reporting in guidelines. (3) Conducting a questionnaire survey to investigate the awareness and information needs of guideline stakeholders regarding health economic evidence in current guidelines. By combining these findings, an initial item pool will be formed. The Delphi method and consensus conference approach will be utilized to establish the RIGHT-Health Economics Checklist.
Results: Preliminary research findings indicate that in the process of guideline development, it is necessary to report on aspects such as whether health economists are included in the guideline panel, how economic evidence is retrieved, the types of economic evidence, the evaluation and summary of economic evidence, the integration of economic evidence with other types of evidence for recommendations, and the consideration of economic levels at the regional level. The remaining research is still ongoing, and the results will be completed before July 1, 2024.